An easy-to-use, low-cost triplex RDT for the simultaneous diagnosis of HBV, HCV, and HIV infection, compatible with field use in lmics and at-home use in the US
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93024C00025
- Awardee
-
Big Eye Diagnostics Inc. UEI C3KTPAW1E1Z7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,659
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · SBIRPHS20241 · Posted Jul 7, 2023
- Contract value 100% obligated
- $299,659.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Original award | $299,659 |
About this award
This federal contract award, valued at $299,659.00, was granted to Big Eye Diagnostics Inc., a small business manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Small Business Innovation Research (SBIR) program and is a Definitive Contract with a Firm Fixed Price pricing type.
The contract is for the development of an "easy-to-use, low-cost triplex RDT for the simultaneous diagnosis of HBV, HCV, and HIV infection, compatible with field use in LMICs and at-home use in the US." This aligns with NIAID's mission to conduct and support research to understand, treat, and ultimately prevent infectious diseases. The contract has a total small business set-aside designation and an ultimate completion date of April 11, 2025.
Quick answers
Who was awarded contract 75N93024C00025?
75N93024C00025 was awarded to Big Eye Diagnostics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2024.
How much is contract 75N93024C00025 worth?
The government has obligated $299,659 on 75N93024C00025.
Was contract 75N93024C00025 competed?
The extent of competition for 75N93024C00025 was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award